India's Blood Stem Cell Donor Gap: A Lifeline in Peril

Aplastic anaemia, a serious blood disorder where bone marrow fails to produce sufficient blood cells, presents a significant health challenge in India. Studies indicate a notable prevalence, often diagnosed in younger patients compared to Western populations. The condition, leading to pancytopenia when red cells, white cells, and platelets are low, necessitates complex medical interventions.

Treatment options include blood stem cell transplants, blood transfusions, and medications. However, regular transfusions carry risks like iron overload and alloimmunisation, making access to donor registries critical. A major hurdle is finding a matching unrelated donor due to a substantial gap in India's stem cell donor registry, which lags far behind countries like Germany and the US.

India's diverse genetic makeup further complicates finding compatible Human Leukocyte Antigen (HLA) matches. This limited donor pool increases the likelihood of prolonged international searches, delays in treatment, high costs, and the emotional distress of losing loved ones. Raising awareness to combat misinformation and persistent myths about stem cell donation's safety and effects is vital.

Expanding India's blood stem cell donor registry requires a large-scale, multifaceted approach. Efforts must include widespread awareness campaigns, donor registration drives, and collaborations with corporations and educational institutions. A collective effort from multiple stakeholders is essential to build a robust registry and provide a lifeline to aplastic anaemia patients.